When using Biodesix Mobile Phlebotomy services, Test Request Forms can be submitted digitally. The Customer Care team takes it from there.
If you are interested in submitting online orders through the Biodesix Physician Portal, contact Customer Care at 866.432.5930 or firstname.lastname@example.org.
The Biodesix Lung Reflex kit contains a Test Request Form and instructions for collecting the blood specimens with the provided collection devices. Package the signed and dated form with the specimen in the kit box and ship in the prepaid FedEx envelope included with each kit.
The GeneStrat® test identifies the most common tumor mutations with guideline-recommended targeted therapies: EGFR, EML4-ALK, KRAS, BRAF, ROS-1, and RET.
These tumor mutations are also the focus of several studies evaluating their potential for adjuvant therapy in resectable early stage NSCLC.
Clinical studies on the VeriStrat® test have repeatedly shown that the test identifies patients with a chronic inflammatory state who have shorter overall survival and should be evaluated for alternative treatment plans and monitored closely for disease progression.
Recent data has also shown the test identifies patients with aggressive early stage disease that may benefit from enhanced disease surveillance or adjuvant treatments.
Test results are delivered in less than 72 hours to provide molecular and prognostic information at the time of the first multi-disciplinary meeting or oncology appointment.
Blood-based molecular testing preserves tissue for other tests that support NSCLC treatment strategies.
Biodesix Lung Reflex testing can be used serially to monitor changes in tumor mutation status or the patient’s immune response to their lung cancer.
Biodesix Lung Reflex is covered by Medicare and many private payers for all patients with NSCLC. This broad coverage allows the testing strategy to be used as a complement to other tests that may only be indicated for patients with advanced stage lung cancer or tests that only covered once per patient.